Home
/ Reactions / Product Dose Omission Issue
Product Dose Omission Issue
Drugs Associated with Product Dose Omission Issue
ADRENALINUM
AFLIBERCEPT
APREMILAST
BELIMUMAB
BURN RELIEF
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE
DULAGLUTIDE
DUPILUMAB
EPINEPHRINE
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE
FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE AND SALMETEROL
FLUTICASONE PROPIONATE NASAL
GALCANEZUMAB-GNLM
GUSELKUMAB
HYDROXYZINE
ISOTRETINOIN
IXAZOMIB
IXEKIZUMAB
LENALIDOMIDE
LIDOCAINE
LIDOCAINE 4%
LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
LIDOCAINE, MENTHOL
MEPOLIZUMAB
METOPROLOL SUCCINATE ER TABLETS
PALIPERIDONE PALMITATE
PIMAVANSERIN TARTRATE
POMALIDOMIDE
RUXOLITINIB
SACUBITRIL AND VALSARTAN
SODIUM CHLORIDE
SOMATROPIN
TIRZEPATIDE
USTEKINUMAB
VEDOLIZUMAB
Disclaimer:
Based on FDA adverse event reports. Not medical advice. Adverse event reports do not prove causation.